This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06984/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB06984/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB06984/identifier/chemspider/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06984/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB06984/identifier/pubchem-compound/

Statements

Subject Item
n2:DB06984
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB06984 n11:DB06984
dcterms:title
(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL
adms:identifier
n4:5290492 n7:6914612 n8:99443455 n13:DB06984 n14:2SK
n5:IUPAC-Name
n6:271B652D-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6533-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6532-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B652F-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6530-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6531-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B652B-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B652C-363D-11E5-9242-09173F13E4C5 n6:271B6529-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B652A-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6539-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B653A-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6534-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6535-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6537-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6536-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6538-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B653F-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6541-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6542-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B653E-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B653D-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B6540-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B652E-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B653B-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B653C-363D-11E5-9242-09173F13E4C5